Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Mesa Laboratories
MLAB
$551M
| $253K | ﹤0.01% |
2,308
-1
| -0% | -$101 |
|
|
OPTU
2302
Optimum Communications Inc
OPTU
$298M
| $252K | ﹤0.01% |
96,105
+8
| +0% | +$20 |
|
2303
Opko Health
OPK
$1.02B
| $252K | ﹤0.01% |
208,463
+14
| +0% | +$14 |
|
2304
Oil States International
OIS
$466M
| $251K | ﹤0.01% |
40,819
+3
| +0% | +$18 |
|
2305
V2X
VVX
$2.7B
| $251K | ﹤0.01% |
5,369
+1
| +0% | +$41 |
|
|
WSR
2306
DELISTED
Whitestone REIT
WSR
| $251K | ﹤0.01% |
20,048
-3
| -0% | -$37 |
|
2307
3D Systems Corp
DDD
$405M
| $251K | ﹤0.01% |
56,628
+2
| +0% | +$10 |
|
2308
Southern Missouri Bancorp
SMBC
$862M
| $251K | ﹤0.01% |
5,716
+1
| +0% | +$45 |
|
2309
Evolus
EOLS
$397M
| $250K | ﹤0.01% |
17,871
+12
| +0.1% | +$156 |
|
2310
Ducommun
DCO
$2.56B
| $250K | ﹤0.01% |
4,869
| – | – |
|
|
SEMR
2311
DELISTED
Semrush
SEMR
| $249K | ﹤0.01% |
18,739
-39
| -0.2% | -$470 |
|
2312
Travere Therapeutics
TVTX
$5.17B
| $248K | ﹤0.01% |
32,181
+1
| +0% | +$8 |
|
2313
TETRA Technologies
TTI
$1.08B
| $247K | ﹤0.01% |
55,973
+7
| +0% | +$29 |
|
2314
Aurinia Pharmaceuticals
AUPH
$1.95B
| $247K | ﹤0.01% |
49,331
| – | – |
|
2315
Cadre Holdings
CDRE
$1.31B
| $246K | ﹤0.01% |
6,806
+18
| +0.3% | +$627 |
|
2316
Tootsie Roll Industries
TR
$2.97B
| $246K | ﹤0.01% |
8,157
-2
| -0% | -$61 |
|
|
EHAB
2317
DELISTED
Enhabit
EHAB
| $245K | ﹤0.01% |
21,080
| – | – |
|
2318
Granite Ridge Resources
GRNT
$621M
| $245K | ﹤0.01% |
37,744
-19,070
| -34% | -$112K |
|
2319
Douglas Dynamics
PLOW
$992M
| $245K | ﹤0.01% |
10,166
| – | – |
|
2320
Oil-Dri
ODC
$1.43B
| $245K | ﹤0.01% |
+6,566
| New | +$226K |
|
2321
FuelCell Energy
FCEL
$1.45B
| $244K | ﹤0.01% |
6,870
+1
| +0% | +$37 |
|
2322
Central Pacific Financial
CPF
$1.02B
| $244K | ﹤0.01% |
12,339
+1
| +0% | +$19 |
|
2323
Lifestance Health
LFST
$4.15B
| $244K | ﹤0.01% |
39,723
+58
| +0.1% | +$391 |
|
|
TRST
2324
Trustco Bank Corp NY
TRST
$953M
| $244K | ﹤0.01% |
8,667
+1
| +0% | +$28 |
|
2325
First Mid Bancshares
FMBH
$1.4B
| $244K | ﹤0.01% |
7,464
| – | – |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.